Article Versions Notes

Hsu J-F, Chu S-M, Liao C-C, Wang C-J, Wang Y-S, Lai M-Y, Wang H-C, Huang H-R, Tsai M-H. Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update. Cancers. 2021; 13(2):195. https://doi.org/10.3390/cancers13020195

Hsu, Jen-Fu, Shih-Ming Chu, Chen-Chu Liao, Chao-Jan Wang, Yi-Shan Wang, Mei-Yin Lai, Hsiao-Chin Wang, Hsuan-Rong Huang, and Ming-Horng Tsai. 2021. "Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update" Cancers 13, no. 2: 195. https://doi.org/10.3390/cancers13020195

Hsu, J.-F., Chu, S.-M., Liao, C.-C., Wang, C.-J., Wang, Y.-S., Lai, M.-Y., Wang, H.-C., Huang, H.-R., & Tsai, M.-H. (2021). Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update. Cancers, 13(2), 195. https://doi.org/10.3390/cancers13020195